Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158266 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Smita Sahay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA. Hauptthemen laut MEDLINE: Diet, Ketogenic, Transcriptome, Mental Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
The disruption of brain energy metabolism, leading to alterations in synaptic signaling, neural circuitry, and neuroplasticity, has been implicated in severe mental illnesses such as schizophrenia, bipolar disorder, and major depressive disorder. The therapeutic potential of ketogenic interventions in these disorders suggests a link between metabolic disturbances and disease pathology; however, the precise mechanisms underlying these metabolic disturbances, and the therapeutic effects of metabolic ketogenic therapy, remain poorly understood. In this study, we conducted an in silico analysis of transcriptomic data to investigate perturbations in metabolic pathways in the brain across severe mental illnesses via gene expression profiling. We also examined dysregulation of the same pathways in rodent or cell culture models of ketosis, comparing these expression profiles to those observed in the disease states. Our analysis revealed significant perturbations across all metabolic pathways, with the greatest perturbations in glycolysis, the tricarboxylic acid (TCA) cycle, and the electron transport chain (ETC) across all three disorders. Additionally, we observed some discordant gene expression patterns between disease states and ketogenic intervention studies, suggesting a potential role for ketone bodies in modulating pathogenic metabolic changes. Our findings highlight the importance of understanding metabolic dysregulation in severe mental illnesses and the potential therapeutic benefits of ketogenic interventions in restoring metabolic homeostasis. This study provides insights into the complex relationship between metabolism and neuropsychiatric disorders and lays the foundation for further experimental investigations aimed at appreciating the implications of the present transcriptomic findings as well as developing targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
- Department of Psychiatry, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
- Neuroscience Institute, ProMedica, Toledo, OH 43614, USA.
ORCID-Profile: Smita Sahay, Robert E McCullumsmith, Sinead M O'Donovan
Förderung
- NIMH NIH HHS
- National Institute of Mental Health
Zitieren
APA
Sahay, S., Pulvender, P., Rami Reddy, M. V. S. R., McCullumsmith, R. E., & O'Donovan, S. M. (2024). Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158266
Vancouver
Sahay S, Pulvender P, Rami Reddy MVSR, McCullumsmith RE, O'Donovan SM. Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158266
BibTeX
@article{Sahay2024,
author = {Sahay, Smita and Pulvender, Priyanka and Rami Reddy, Madhu Vishnu Sankar Reddy and McCullumsmith, Robert E and O'Donovan, Sinead M},
title = {Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158266}
}
EUVIMED